StopDown
Funding · 6 January 2026FutureCure Health₹104 crore ($11.5 million)Vertigo diagnosis and treatment

FutureCure Health raises ₹104 crore for vertigo care

By · Editor ·

Founded 2015
  • FutureCure Health is a healthcare technology company focused on super-speciality care
  • It raised ₹104 crore ($11.5 million) led by Carnelian Asset Management LLP
  • The company plans to expand vertigo diagnosis and treatment globally and into chronic conditions like migraine

What happened

  • FutureCure Health raised ₹104 crore ($11.5 million) in a funding round.
  • The round was led by Carnelian Asset Management LLP with participation from other marquee investors.
  • The company will use the funds to expand access to vertigo diagnosis and treatment in India and globally.
  • It also plans to expand into chronic lifestyle conditions such as migraine and diabetes.
  • FutureCure Health's subsidiary NeuroEquilibrium is the world's largest chain of vertigo and dizziness clinics.
  • The company has over 300 clinics in India and 16 other countries.
  • It has diagnosed and treated over 150,000 patients.

Why it matters

  • Vertigo and balance disorders affect nearly six crore people in India, many facing delayed or incorrect diagnoses.
  • The company's approach identifies the root cause of vertigo for targeted treatment, not symptom suppression.
  • Co-founder Anita Bhandari is a globally recognised expert in vertigo and balance disorders.

The business

  • FutureCure Health is a healthcare technology company focused on super-speciality care.
  • Its wholly owned subsidiary NeuroEquilibrium operates the world's largest chain of vertigo and dizziness clinics.
  • The company integrates advanced diagnostic systems, cloud-based remote platforms, and deep-tech innovation.
  • It works with hospitals, ENT clinics, and neurology centres.
  • The company has over 300 clinics in India and 16 other countries.
  • It has served over 150,000 patients.
  • The technology enables precision neuro-otology care beyond urban centres.

The founders

Rajneesh Bhandari

co-founder
  • Rajneesh Bhandari is an IIT Delhi alumnus.
  • He is a serial entrepreneur.
  • He said globally relevant healthcare technologies can be built in India.

Anita Bhandari

co-founder
  • Anita Bhandari is a globally recognised expert in vertigo and balance disorders.
  • She said accurate diagnosis changes outcomes and the funding helps take vertigo care global.

Who put in money

  • Carnelian Asset Management LLP lead

In numbers

over 300clinics
over 150,000patients served
16countries with clinics

Earlier rounds

  • 2022 · $4 million · led by Kotak Alternate Asset Management

Words to know

vertigo
A sensation of spinning or dizziness, often caused by problems in the inner ear or brain.
neuro-otology
A medical specialty dealing with disorders of the nervous system related to hearing and balance.
super-speciality care
Highly specialised medical care focused on a specific organ, disease, or patient group.

The numbers around it

Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Private limited company: A private limited company is the usual choice for Indian startups that plan to raise venture capital, because it can issue shares, ESOPs and preference instruments under the Companies Act, 2013. An LLP, governed by the LLP Act, 2008, is simpler and cheaper but cannot issue shares, so it suits small businesses that will not raise equity.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 6 January 2026 →

Is this FutureCure Health? Get your “Featured on StopDown” badge →